{"entity":{"type":"insider","cik":"0002019645","url":"/insider/0002019645","json_url":"/insider/0002019645.json","name":"Bruno Julianne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2024-06-24","last":"2025-03-24","span_basis":"filed_date"},"name_variants":[{"name":"Bruno Julianne","source":"filing","n_filings":4,"first_seen":"2024-06-24","last_seen":"2025-03-24"}],"transactions":[{"id":4340865,"accession":"0000950170-25-043974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-043974","line_url":"/filing/0000950170-25-043974#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0002019645","owner_name":"Bruno Julianne","owner_display_name":"Bruno Julianne","owner_url":"/insider/0002019645","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1714.0,"shares_display":"1,714","price_per_share":41.23,"price_display":"41.23","price_state":"stated","total_value":70668.22,"total_display":"70,668.22","total_whole":"70,668","shares_owned_after":10544.0,"shares_owned_after_display":"10,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-24","scope":"insider"},{"id":4312334,"accession":"0000950170-25-038214","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-038214","line_url":"/filing/0000950170-25-038214#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0002019645","owner_name":"Bruno Julianne","owner_display_name":"Bruno Julianne","owner_url":"/insider/0002019645","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":190.0,"shares_display":"190","price_per_share":43.32,"price_display":"43.32","price_state":"stated","total_value":8230.8,"total_display":"8,230.80","total_whole":"8,231","shares_owned_after":8508.0,"shares_owned_after_display":"8,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4312330,"accession":"0000950170-25-038214","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-038214","line_url":"/filing/0000950170-25-038214#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0002019645","owner_name":"Bruno Julianne","owner_display_name":"Bruno Julianne","owner_url":"/insider/0002019645","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1198.0,"shares_display":"1,198","price_per_share":42.42,"price_display":"42.42","price_state":"stated","total_value":50819.16,"total_display":"50,819.16","total_whole":"50,819","shares_owned_after":8263.0,"shares_owned_after_display":"8,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-12","scope":"insider"},{"id":4099352,"accession":"0000950170-25-023387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-023387","line_url":"/filing/0000950170-25-023387#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0002019645","owner_name":"Bruno Julianne","owner_display_name":"Bruno Julianne","owner_url":"/insider/0002019645","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":333.0,"shares_display":"333","price_per_share":52.8,"price_display":"52.80","price_state":"stated","total_value":17582.4,"total_display":"17,582.40","total_whole":"17,582","shares_owned_after":7062.0,"shares_owned_after_display":"7,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-19","scope":"insider"},{"id":3255049,"accession":"0000950170-24-076916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-076916","line_url":"/filing/0000950170-24-076916#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0002019645","owner_name":"Bruno Julianne","owner_display_name":"Bruno Julianne","owner_url":"/insider/0002019645","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3366.0,"shares_display":"3,366","price_per_share":56.09,"price_display":"56.09","price_state":"stated","total_value":188798.94,"total_display":"188,798.94","total_whole":"188,799","shares_owned_after":6745.0,"shares_owned_after_display":"6,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-21","filed_date":"2024-06-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Officer (Chief Operating Officer)","n_filings":4,"first_seen":"2024-06-24","last_seen":"2025-03-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002019645","retrieved_at":"2026-08-23T05:36:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}